Cellectis SA (CLLS)

4.23 +0.25 (+6.28%) USD  |  NASDAQ  |  Feb 25, 11:09
More

Cellectis Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
EDAP TMS SA Upgrade
DBV Technologies SA --
Ascendis Pharma A/S Upgrade
Akari Therapeutics Plc --
Biodexa Pharmaceuticals Plc --